Skip to main content

Wellgistics Health, Inc.

Qualité des données : 100%
WGRX
Nasdaq Wholesale Trade Nondurable Goods Wholesale
0,11 €
▼ 0,02 € (-15,87%)
Cap. Boursière: 12,74 M
Prix
0,11 €
Cap. Boursière
12,74 M
Fourchette du Jour
0,10 € — 0,12 €
Fourchette 52 Semaines
0,10 € — 7,04 €
Volume
9 357 272
Ouverture 0,12 €
Moyenne 50J / 200J
0,23 €
53,12% below
Moyenne 50J / 200J
0,65 €
83,77% below

Quick Summary

Points Clés

Debt/Equity of 3,66 — high leverage
Negative free cash flow of -5,79 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)-22,32%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-2089,68%
En dessous de la moyenne du secteur (-3,22%)
ROIC-369,67%
Net Margin-201,72%
Op. Margin-187,31%

Sécurité

Debt / Equity
3,66
Au-dessus de la moyenne du secteur (0,33)
Current Ratio0,39
Interest Coverage-16,44

Valorisation

PE (TTM)
-0,16
En dessous de la moyenne du secteur (-0,15)
P/B Ratio1,88
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Wholesale Trade (91 pairs)
Métrique Action Médiane du Secteur
P/E -0,2 -0,2
P/B 1,9 1,0
ROE % -2089,7 -3,2
Net Margin % -201,7 -2,2
Rev Growth 5Y % 2,6
D/E 3,7 0,3

All Fundamental Metrics

Growth
Revenue Growth (1Y) -22,32% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 39,80 M Net Income (TTM) -80,28 M
ROE -2089,68% ROA -150,05%
Gross Margin 8,03% Operating Margin -187,31%
Net Margin -201,72% Free Cash Flow (TTM) -5,79 M
ROIC -369,67% FCF Growth (3Y) N/A
Safety
Debt / Equity 3,66 Current Ratio 0,39
Interest Coverage -16,44 Asset Turnover 0,74
Working Capital -19,92 M Tangible Book Value -11,69 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,16 Forward P/E N/A
P/B Ratio 1,88 P/S Ratio 0,32
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -45,44%
Market Cap 12,74 M Enterprise Value 33,32 M
Per Share
EPS (Diluted TTM) -1,33 Revenue / Share 0,33
FCF / Share -0,05 OCF / Share -0,05
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 7,21%
SBC-Adj. FCF -6,87 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2025
Revenue 18,13 M 23,34 M
Net Income -6,86 M -101,27 M
EPS (Diluted) -0,15 -1,43
Gross Profit 1,77 M -6,43 M
Operating Income -6,15 M -93,75 M
EBITDA
R&D Expenses
SG&A Expenses
D&A 1,11 M 3,21 M
Interest Expense 831 467,0 4,58 M
Income Tax

Balance Sheet

Annual, most recent first
Metric FY2024 FY2025
Total Assets 57,33 M 30,46 M
Total Liabilities 50,60 M 42,91 M
Shareholders' Equity 6,73 M -12,45 M
Total Debt 23,38 M 23,49 M
Cash & Equivalents 1,03 M 42 571,0
Current Assets 15,17 M 2,82 M
Current Liabilities 38,05 M 29,78 M